Phenomapping a Novel Classification System for Patients With Destination Therapy Left Ventricular Assist Devices
Section snippets
Disclosures
Dr. Grodin receives grant support from Texas Health Resources. Dr. Grodin reports relations with Pfizer Inc that includes consulting or advisory. Dr. Grodin reports relations with Alnylam Pharmaceuticals Inc that includes consulting or advisory. Dr. Grodin reports relations with Eidos Therapeutics that includes consulting or advisory and funding grants. Dr. Grodin reports relations with Sarepta Therapeutics Inc that includes consulting or advisory. Dr. Pandey receives a grant support from Texas
Funding sources
JLG reports research funding from the Texas Health Resources Clinical Scholarship and Eidos and AP reports research funding from the Texas Health Resources Clinical Scholarship. MHD is supported by the James M. Wooten Chair in Cardiology.
References (14)
- et al.
The Society of Thoracic Surgeons intermacs database annual report: evolving indications, outcomes, and scientific partnerships
Ann Thorac Surg
(2019) - et al.
Increased right-to-left ventricle diameter ratio is a strong predictor of right ventricular failure after left ventricular assist device
J Heart Lung Transplant
(2013) - et al.
Validation of clinical scores for right ventricular failure prediction after implantation of continuous-flow left ventricular assist devices
J Heart Lung Transplant
(2015) - et al.
Pump thrombosis in the Thoratec HeartMate II device: an update analysis of the INTERMACS registry
J Heart Lung Transplant
(2015) - et al.
Current risks of HeartMate II pump thrombosis: non-parametric analysis of Interagency Registry for Mechanically Assisted Circulatory Support data
J Heart Lung Transplant
(2015) - et al.
Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon
J Heart Lung Transplant
(2014) - et al.
Novel model to predict gastrointestinal bleeding during left ventricular assist device support
Circ Heart Fail
(2018)
Cited by (1)
Artificial intelligence guidance of advanced heart failure therapies: A systematic scoping review
2023, Frontiers in Cardiovascular Medicine
Dr. Grodin receives a grant from Texas Health Resources. Dr. Grodin receives grants from Eidos Therapeutics. Dr. Pandey receives funding from Texas Health Resources. Dr. Drazner receives grants from James M. Wooten Chair in Cardiology.